Quote | Shield Therapeutics PLC (OTCMKTS:SHIEF)
Last: | $0.0192 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0192 |
Close: | $0.0192 |
High: | $0.02 |
Low: | $0.019 |
Volume: | 1,269,822 |
Last Trade Date Time: | 04/15/2024 03:00:00 am |
News | Shield Therapeutics PLC (OTCMKTS:SHIEF)
(NewsDirect) Proactive Research Analyst Robin Davison speaks to Thomas Warner after publishing a new research note on iron defiency-focused commercial-stage specialty pharmaceutical company Shield Therapeutics. Davison gives an overview of what readers can expect from the note, highli...
(NewsDirect) Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) CEO Greg Madison speaks to Thomas Warner after a busy week for the commercial stage pharmaceutical company, which included the release of its interim results and the announcement of a major fundraise. He highlights the succes...
Message Board Posts | Shield Therapeutics PLC (OTCMKTS:SHIEF)
Subject | By | Source | When |
---|---|---|---|
$SHIEF: Accrufer accepted by Health Canada | makinezmoney | investorshub | 07/14/2022 10:54:06 AM |
News, Short Squeeze, Breakout and More Instantly...
Shield Therapeutics PLC Company Name:
SHIEF Stock Symbol:
OTCMKTS Market:
(NewsDirect) Proactive Research Analyst Robin Davison speaks to Thomas Warner after publishing a new research note on iron defiency-focused commercial-stage specialty pharmaceutical company Shield Therapeutics. Davison gives an overview of what readers can expect from the note, highli...
(NewsDirect) Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) CEO Greg Madison speaks to Thomas Warner after a busy week for the commercial stage pharmaceutical company, which included the release of its interim results and the announcement of a major fundraise. He highlights the succes...
(NewsDirect) Proactive Research Analyst Robin Davison speaks to Thomas Warner after publishing a new research note on Shield Therapeutics PLC, following the release of new prescription data from the commercial-stage specialty pharmaceutical company for its iron deficiency treatment Accruf...